Heart transplant patients from socioeconomically disadvantaged neighborhoods face a higher risk of complications and earlier death, even when receiving care at top-tier hospitals, according to a new UCLA study. The research, published in the Journal of Heart and Lung Transplantation, reveals that neighborhood deprivation significantly impacts post-transplant survival rates.
Â
Examining data from over 38,000 heart transplant recipients, researchers found that patients from the most deprived areas had a 14% higher risk of dying within three years and a 13% higher chance within five years post-transplant. These patients also faced an increased risk of organ failure.
Â
Lead author Sara Sakowitz, a medical student at UCLA, emphasized that access to high-quality transplant centers alone does not mitigate these disparities. “Factors outside the immediate post-transplantation period, stemming from access to longitudinal care or crucial immunosuppressive medications, appear to be implicated,” Sakowitz explained.
Â
The study utilized the Area Deprivation Index to rank neighborhoods based on socioeconomic factors. Even after adjusting for race, insurance, and comorbidities, the disparity persisted, suggesting that community-level disadvantage independently shapes transplant outcomes.
Â
Researchers are now exploring additional factors contributing to this gap, including access to post-transplant medication and environmental influences on health. Sakowitz stressed the importance of addressing systemic root causes, stating, “To tackle disparities in transplantation, we must break down these large-scale problems into inflection points where we can make meaningful change.”
Â
This research underscores the need for comprehensive strategies that extend beyond the initial transplant procedure, focusing on long-term care and support for patients from disadvantaged communities to improve their chances of survival and quality of life post-transplant.
Â
See “Heart transplant patients from deprived areas face higher risk for postoperative complications, earlier death” (September 30, 2024)
Â


